TrialPloS one2018

Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes.

Robert R Henry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.